Masimo Corporation
MASI
Rang in aandelen
#2166
Masimo Corporation engages in the development, manufacture, and marketing of... Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
Aandeelprijs
$179.95
Laatst gesynchroniseerd: 2026-06-12
Marktkapitalisatie
$9.42B
Verandering (1 dag)
0.00%
Verandering (1 jaar)
22.41%
Land
US
Handel Masimo Corporation (MASI)
Categorie
Healthcare
Winst voor Masimo Corporation (MASI)
Winst in Apr 2026 TTM: $275.60M
Volgens de meest recente financiële verslagen van Masimo Corporation bedraagt de huidige winst van het bedrijf $275.60M. In 2023 behaalde het bedrijf een winst van $88.10M, een daling ten opzichte van de winst van 2022, die $193.40M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Masimo Corporation van 2002 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $275.60M | -190.27% |
| 2024 | $-305.30M | -446.54% |
| 2023 | $88.10M | -54.45% |
| 2022 | $193.40M | -29.52% |
| 2021 | $274.40M | 4.06% |
| 2020 | $263.70M | 12.61% |
| 2019 | $234.17M | 9.54% |
| 2018 | $213.78M | 15.06% |
| 2017 | $185.80M | -57.14% |
| 2016 | $433.52M | 272.61% |
| 2015 | $116.35M | 14.02% |
| 2014 | $102.04M | 34.75% |
| 2013 | $75.73M | -9.66% |
| 2012 | $83.82M | -3.13% |
| 2011 | $86.53M | -19.56% |
| 2010 | $107.57M | 30.89% |
| 2009 | $82.18M | 13.52% |
| 2008 | $72.39M | 6.27% |
| 2007 | $68.12M | -78.33% |
| 2006 | $314.40M | 4,166.56% |
| 2005 | $7.37M | 0.00% |
| 2004 | 0.00 | -100.00% |
| 2003 | $-6.89M | 3,707.73% |
| 2002 | $-181.00K | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $7.51B | 2,625.33% |
US
|
|
| $5.56B | 1,918.51% |
IE
|
|
| $5.15B | 1,767.92% |
US
|
|
| $3.86B | 1,300.94% |
US
|
|
| - | - |
DE
|
